<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
  • Menu
  • crown-logo-symbol-1-400x551

Find it Quickly

Get Started

Select the option that best describes what you are looking for

  • Services
  • Models
  • Scientific Information

Search Here For Services

Click Here to Start Over

Search Here For Models

Click Here to Start Over

Search Here For Scientific Information

Click Here to Start Over

In Vitro

Boost oncology drug discovery with XenoBase®, featuring the largest cell line selection and exclusive 3D organoid models. Benefit from OrganoidXplore™ and OmniScreen™ for rapid, in-depth analysis.

Learn More

In Vivo

Enhance drug development with our validated in vivo models, in vitro/ex vivo assays, and in silico modeling. Tailored solutions to optimize your candidates.

Learn More

Tissue

Experience ISO-certified biobanking quality. Access top biospecimens from a global clinical network, annotated by experts for precise research.

Learn More

Biomarkers and Bioanalysis

Leverage our global labs and 150+ scientists for fast, tailored project execution. Benefit from our expertise, cutting-edge tech, and validated workflows for reliable data outcomes.

Learn More

Data Science and Bioinformatics

Harness your data and discover biomarkers with our top bioinformatics expertise. Maximize data value and gain critical insights to accelerate drug discovery and elevate projects.

Learn More

KRAS

Accelerate innovative cancer treatments with our advanced models and precise drug screening for KRAS mutations, efficiently turning insights into clinical breakthroughs.

Learn More

EGFR

Advance translational pharmacology with our diverse pre-clinical models, robust assays, and data science-driven biomarker analysis, multi-omics, and spatial biology.

Learn More

Drug Resistance

Our suite integrates preclinical solutions, bioanalytical read-outs, and multi-omics to uncover drug resistance markers and expedite discovery with our unique four-step strategy.

Learn More

Patient Tissue

Enhance treatments with our human tumor and mouse models, including xenografts and organoids, for accurate cancer biology representation.

Learn More

Target to Lead Selection for ADCs and Biologics

Journey through the drug discovery pipeline from target discovery to in vivo pharmacology. Take advantage of the Largest biobank of patient-derived models, Model development capabilities, Cell-based assays for Screening ADCs, and advanced downstream analysis.

Learn More

Immuno-oncology Targets & Combinations

Leverage comprehensive in vitro, in vivo, ex vivo, and in silico platforms, utilizing immunocompetent, humanized, or patient-derived models. With robust biomarker analysis and a focus on checkpoint inhibitors, you can optimize combination strategies.

Learn More

Bioinformatics

Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.

Learn More

Biomarker Analysis

Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.

Learn More

CRISPR/Cas9

Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies.

Learn More

Genomics

Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.

Learn More

In Vitro High Content Imaging

Gain more insights into tumor growth and disease progression by leveraging our 2D and 3D fluorescence optical imaging.

Learn More

Mass Spectrometry-based Proteomics

Next-generation ion mobility mass spectrometry (MS)-based proteomics services available globally to help meet your study needs.

Learn More

Ex Vivo Patient Tissue

Gain better insight into the phenotypic response of your therapeutic candidate in organoids and ex vivo patient tissue.

Learn More

Spatial Multi-Omics Analysis

Certified CRO services with NanoString GeoMx Digital Spatial Profiling.

Learn More

Biomarker Discovery

De-risk your drug development with early identification of candidate biomarkers and utilize our biomarker discovery services to optimize clinical trial design.

Learn More

DMPK Services

Rapidly evaluate your molecule’s pharmaceutical and safety properties with our in vivo drug metabolism and pharmacokinetic (DMPK) services to select the most robust drug formulations.

Learn More

Efficacy Testing

Explore how the novel HuGEMM™ and HuCELL™ platforms can assess the efficacy of your molecule and accelerate your immuno-oncology drug discovery programs.

Learn More

Laboratory Services

Employ cutting-edge multi-omics methods to obtain accurate and comprehensive data for optimal data-based decisions.

Learn More

Pharmacology & Bioanalytical Services

Leverage our suite of structural biology services including, recombinant protein expression and protein crystallography, and target validation services including RNAi.

Learn More

Screens

Find the most appropriate screen to accelerate your drug development: discover in vivo screens with MuScreen™ and in vitro cell line screening with OmniScreen™.

Learn More

Toxicology

Carry out safety pharmacology studies as standalone assessments or embedded within our overall toxicological profiling to assess cardiovascular, metabolic and renal/urinary systems.

Learn More

Preclinical Consulting Services

Learn more about how our consulting services can help to support your journey to the clinic.

Learn More

Our Company

Global CRO in California, USA offering preclinical and translational oncology platforms with high-quality in vivo, in vitro, and ex vivo models.

Learn More

Our Purpose

Learn more about the impact we make through our scientific talent, high-quality standards, and innovation.

Learn More

Our Responsibility

We build a sustainable future by supporting employee growth, fostering leadership, and exceeding customer needs. Our values focus on innovation, social responsibility, and community well-being.

Learn More

Meet Our Leadership Team

We build a sustainable future by fostering leadership, employee growth, and exceeding customer needs with innovation and social responsibility.

Learn More

Scientific Advisory Board

Our Scientific Advisory Board of experts shapes our strategy and ensures top scientific standards in research and development.

Learn More

News & Events

Stay updated with Crown Bioscience's latest news, achievements, and announcements. Check our schedule for upcoming events and plan your visit.

Learn More

Career Opportunities

Join us for a fast-paced career addressing life science needs with innovative technologies. Thrive in a respectful, growth-focused environment.

Learn More

Scientific Publications

Access our latest scientific research and peer-reviewed articles. Discover cutting-edge findings and insights driving innovation and excellence in bioscience.

Learn More

Resources

Discover valuable insights and curated materials to support your R&D efforts. Explore the latest trends, innovations, and expertly curated content in bioscience.

Learn More

Blogs

Explore our blogs for the latest insights, research breakthroughs, and industry trends. Stay educated with expert perspectives and in-depth articles driving innovation in bioscience.

Learn More

  • Platforms
  • Target Solutions
  • Technologies
  • Service Types
Background Image

Microbiome Sequencing

Understanding the microbiome using genomic sequencing and analysis

Microbiome study is vital for drug discovery as the microbiome significantly influences drug metabolism, efficacy, and safety. Understanding these interactions can optimize drug dosages, enhance treatment effectiveness, and enable personalized medicine based on an individual's unique microbiome profile. Moreover, the microbiome's impact on drug-induced toxicity and interactions between medications can be identified, leading to safer drug development. Microbiome-targeted therapies offer promising approaches, directly treating conditions or improving drug effects. Microbiome analysis also helps identify biomarkers for diseases and treatment response, advancing diagnostic tools and precision medicine. Integrating microbiome data into drug development can revolutionize healthcare by improving treatment outcome

Microbiome sequencing provids insights into complex microbial communities. Choose our microbiome sequencing services for:

  • Diverse service options: We offer multiple methods for comprehensive microbiome sequencing analysis, including full-length 16s rRNA sequencing, shotgun metagenomic sequencing, and metatranscriptomic sequencing

  • Superior data quality and advanced technology platforms: Our services utilize Illumina NovaSeq and PacBio platforms, ensuring accurate and high-quality sequencing for comprehensive microbiome analysis.

  • Expert data analysis: Our experienced bioinformatics team provides in-depth data interpretation and analysis.

  • In vivo service integration: Gain valuable insights into host-microbiome interactions through access to our in vivo service. 

Start Your Study

Full-length 16s rRNA Sequencing

Crown Bioscience leads in comprehensive and cost-effective full-length 16S rRNA analysis using PacBio's long-read third-generation sequencing. Our approach offers distinct advantages over short read sequencing. By capturing the entire 16S rRNA gene, we provide unparalleled insights into bacterial diversity and ensure precise taxonomic classification. Overcoming limitations of short read methods, such as primer bias and reduced taxonomic resolution, our full-length sequencing delivers a comprehensive and unbiased view of the microbial community. This empowers the identification of potential drug targets and deepens understanding of their functional roles.

 

Traditional 16S Sequencing

Full-Length 16S Sequencing

  Sequencing Platform

  Short Read Sequencing

  Long Read Sequencing 

  Targeted Region

  Short hypervariable region

  Entire 16S rRNA gene

  Taxonomic Resolution

  Moderate

  Higher

  Primer Bias

  Yes

  Reduced

  Secondary Structure

  Not captured

  Captured

 

Fig. Commonly used DNA regions in short-read and long-read 16S rRNA sequencing

Shotgun Metagenomic Sequencing

Metagenomic sequencing provides a significant advantage over 16S rRNA sequencing by capturing comprehensive genomic information. This empowers higher taxonomic resolution, direct functional profiling, and the identification of novel or rare species. While it comes at a higher cost and requires specialized bioinformatics expertise, shotgun sequencing is an ideal choice for researchers looking to delve into a smaller number of samples with greater depth compared to amplicon sequencing. Embrace the power of metagenomic sequencing to unlock a wealth of valuable insights about microbial communities and their functional potential.

Metatranscriptomic Sequencing 

Metatranscriptomic sequencing studies the gene expression profiles of microbial communities, providing insights into their functional activities and responses to the environment. By analyzing RNA molecules, researchers can identify actively expressed genes, revealing the metabolic pathways and biological processes within the microbiome. This approach enhances our understanding of how microbes interact with their surroundings and contribute to ecosystem functions and host-associated processes.

 
Swipe left to view the entire table on mobile
 
 

Methods

Applications

Advantages

Limitations

Full-length 16S rRNA 
Sequencing

  • Identification, classification, and quantification of microbes (bacteria) within complex biological mixtures
  • Microbial contamination detection
  • Cost-effective
  • Established pipeline for data analysis
  • Well-developed database
  • Potential PCR amplification bias
  • Relatively low taxonomic resolution (genus-species)
  • Focuses on bacterial microbes only

Shotgun Metagenomic
Sequencing

  • Comprehensive sequencing of all genes in all organisms (bacteria, fungi, etc.) present in a given complex sample
  • High taxonomic resolution (species-strains)
  • Improved sequencing depth and accuracy
  • Increased detection of microbial diversity
  • Functional profiling
  • Relatively higher cost
  • Longer sequencing period
  • Challenges with database completeness and reference availability

Metatranscriptomic
Sequencing

  • Capturing and studying the expressed transcripts within a microbiome at a specific time and environmental condition
  • Whole gene expression profiling
  • Functional enrichment analysis
  • Insight into active members of the microbiome
  • Study of microbiome-host and microbiome-environment interactions
  • Relatively higher cost
  • Longer sequencing period
  • Limited availability of reference genomes

Related Resources

Microbiome Sequencing Image
Download Now
Understanding the Microbiome Using Genomic Sequencing and Analysis Image
Read now

Learn More about Our Microbiome Sequencing Service

Contact our experts for genomics research support.

Contact Us